Some of the content on this website requires JavaScript to be enabled in your web browser to function as intended. While the website is still usable without JavaScript, it should be enabled to enjoy the full interactive experience.

Skip to Main Content

School of Pharmacy|College of Health Sciences

Lawrence B. Staubach, M.D., M.B.A.

Assistant Professor, Social and Administrative Pharmacy

lstaubac@uwyo.edu • (307) 766-6113 • HS 465

Dr. Staubach joined the School of Pharmacy in March 2012 as an Assistant Professor of Social & Administrative Pharmacy in the College of Health Sciences. He received his undergraduate B.A. in chemistry and biology from the University of Dayton. He received his M.D. from the University of Cincinnati followed by post-graduate medical training in Internal Medicine (PGYI) and Diagnostic Radiology from the Christ Hospital and the University of Cincinnati, respectively. Dr. Staubach has also earned an MBA from Xavier University with concentrations in management and marketing.

Dr. Staubach is a seasoned physician-executive and scientist with a proven track record of successfully commercializing products and services over a 24 year career in diverse industries including health care delivery, health insurance, pharmaceutical, OTC, beauty care, and food & beverage. He has built, led, and managed domestic and global cross-functional teams and functional organizations focusing on Phase III/IV drug research, drug information, pharmacovigilance, health economics & outcomes research, CME/CE professional education, and scientific publications. He has also served as a medical and customer marketing director on a $3 billion brand as a member of the marketing department in a leading pharmaceutical company.

Dr. Staubach’s teaching interests lie at the intersection of business, the marketplace, and medicine/pharmacy. His corporate teaching experience includes global strategy development and deployment, branding, business to business selling, managed care marketing, and business ethics/compliance. His research interests include the evolving role and relevance of social and administrative science skill sets in improving individual and public health and the identification and resolution of any gaps between current social and administrative pharmacy curricula and marketplace/practice needs.

Education:

Marketing MBA Concentration, 2008, Xavier University

Master of Business Administration (Management), 1991, Xavier University

Diagnostic Imaging Diploma, 1985, University of Cincinnati

Internal Medicine/First Post-graduate Year Diploma, 1982, The Christ Hospital

Medical Doctorate, 1981, University of Cincinnati

Bachelor of Arts(Biology-Chemistry), 1976, University of Dayton

Professional Experience:

•    July 2012-Present.  2012-2013 Inaugural NACDS Foundation Faculty Scholar.  National Association of Chain Drug Stores.

•    2012-Present.  Assistant Professor, Social and Administrative Pharmacy.  College of Health Sciences, School of Pharmacy.  University of Wyoming

•    2007-Present.  Principal and Founder.  Staubach Healthcare Group LLC

•    2006-2007.  Vice President, Global Medical Affairs & Pharmacovigilance.  Stiefel Laboratories, Inc.

•    2005-2006.  Director, Prevacid Medical & Customer Marketing.  TAP Pharmaceutical Products Inc.,

•    2002-2005.  Director, Medical Affairs.  TAP Pharmaceutical Products Inc.,

•    2001-2002.  CEO and Medical Director.  Staubach Healthcare.

•    1995-2001.  Director, Health System Affairs and, Medical Director, Healthcare Consumer Institute (HCI).  The Procter and Gamble Company.

•    1995-1999.  Medical Director, Personal Health Improvement Program.  The Procter and Gamble Company.

•    1993-1995.  Medical Director, Olestra Clinical and Medical Affairs – Foods and Beverage Division.  The Procter and Gamble Company.

•    1991-1993.  Medical Director, Worldwide Medical Affairs – Non-Prescription Medicines.  The Procter and Gamble Company.

•    1990-1991.  Clinical Research Scientist.  Marion Merrell Dow Inc. (formerly Merrell Dow Pharmaceuticals Inc.)

•    1988-1990.  Director, Medical Drug Experience Surveillance Center (MDESC).  Marion Merrell Dow Inc. (formerly Merrell Dow Pharmaceuticals Inc.)

•    1987-1988.  Senior Consultant: Quality Management, Risk Management and Legal Medicine.  AIG Consultants, Inc.

•    1985-1987.  Attending Radiologist.  Bedford Medical Center and Dunn Memorial Hospital

Teaching:

PHCY 6241 Organizational/Societal Issues

PHCY 6242 Pharmacy Administration

PHCY 6250 Drug Literature Evaluation

Research and Scholarship:

Publications (Refereed Journals):

Aforismo, John, Kaul, Alan, Tomondy, Paul, Parry, Gregory, Staubach, Lawrence, Regalli, Gino and Dine, Alan. “Flouroquinolone use for acute cystitis in an IPA-model managed care organization.” Am J Health-System Pharm. 52 (1995):2702-4. Print.

Staubach, L.B. “Enlarged Optic Nerve: A Computerized Tomography Gamut.” Seminars in Roentgenology. Vol. XIX. No. 2 (1983). Print.

Publications (Refereed Book and Monograph Chapters):

Staubach, L.B., Johnson, P.B. and Millar, A.P. Chapter 10, “High Utilizers of Health Services:  The Purchaser Perspective and Experience With the Personal Health Improvement Program.”  Primary Care Meets Mental Health-Tools For The 21st Century. Ed. Haber, J.D and Mitchell, G.E. Tiburon: Centralink Publications, 1997. 99-113. Print.

Publications (Book Reviews):

Staubach, L.B., Orthopaedic Positioning in Diagnostic Radiology Edited by Andreas Bernan and Thomas H. Berquist, translated by Allan Lake Rice.  Urban and Schwartzenberg Inc., 1983.  The Journal of Emergency Medicine. Vol. XIX, p. 83, No. 2 (April 1984). Print.

Publications (Other):

Staubach, L.B.  “Introduction To The Consumer Health Institute”.  Inside AMGA, Newsletter of the American Medical Group Association.  Vol. 1, No. 1. (2001): 4. Print.

Staubach, L.B.  “Strategy Development and Deployment System-Introduction.”  Inside AMGA, Newsletter of the American Medical Group Association.  Vol. 1, No. 2. (2001): 4. Print.

Staubach, L.B.  “Strategy Development and Deployment System-PDCA.”  Inside AMGA, Newsletter of the American Medical Group Association.  Vol. 1, No. 3. (2001): 4. Print.

Staubach, L.B.  “Strategy Development and Deployment System-Market Insight Into Strategy.”  Inside AMGA, Newsletter of the American Medical Group Association.”  Vol. 1, No. 4. (2001): 4. Print.

Staubach, L.B.  “Strategy Development and Deployment System-Decision-Mapping.”  Inside AMGA, Newsletter of the American Medical Group Association.”  Vol. 1, No. 5. (2001) ): 4. Print.

Staubach, L.B.  “Strategy Development and Deployment System-Decision Benefits.”  Inside AMGA, Newsletter of the American Medical Group Association.  Vol. 1, No. 6.  (2001) ): 4. Print.

Staubach, L.B., Global STAR 1.0 Instructor’s Guide.  Cincinnati: PDG Inc., 1999.  Print.

Staubach, L.B., Global STAR 1.0 Participant’s Guide.  Cincinnati: PDG Inc., 1999.  Print.

Staubach, L.B., Global STAR 1.0 Quick Reference Guide. Cincinnati: PDG Inc., 1999.  Print.

Presentations (Refereed National and International Abstracts):

Whipps, D, Zebrowski, L, Aseneta, M.A., Staubach, L.B., Tomondy, P.A., Dine, A., Parry, G.E.,  “Flouroquinolone DUE for Acute Cystitis in a MCO.”  7th Annual Meeting of the Academy of Managed Care Pharmacy.  (1995, May).  Poster presentation.

Aforismo J, Kaul A, Tomondy P, Parry G, Staubach LB, Regalli G, and Dine A.  “Flouroquinolone use for acute cystitis in an IPA-model managed care organization.”  The American College of Clinical Pharmacy Winter Practice and Research Forum.  Orlando, FL. (1995, February).  Conference presentation.

Presentations (Other):

Staubach, L.B. and Sabouni, A.,  “Successful Regulatory Filing and Approval Based on "Well-Understood" Clinical Supplies/Trials.”  IQPC Clinical Trials Logistics.  Philadelphia, PA.  (2009, December).  Conference workshop.

Staubach, L.B.,  “KOL 101- Implementing and Designing New KOL Programs.”  The CBI 4th Annual Defining Appropriate and Effective Interactions With Thought Leaders and Key Opinion Leaders (KOLs).  Philadelphia, PA. (2007, November).  Conference presentation.

Staubach, L.B.,  “Identify and Overcome Potential Conflict of Interest Issues with KOLs.”  The CBI 4th Annual Defining Appropriate and Effective Interactions With Thought Leaders and Key Opinion Leaders (KOLs).  Philadelphia, PA. (2007, November).  Conference presentation.

Staubach, L.B.,  “International Studies-Develop a Strategic Approach to Global Investigator Initiated Studies.”  Maximize Investigator-Initiated Studies-Improve Process Management, Maintain Compliance and Ensure Study Completion.  Trenton, NJ.  (2007, March).  Conference presentation.

Staubach, L.B.,  “Achieve Strategic and Compliant Alignment Between Marketing and Medical/Clinical Affairs.”  CBI’s 7th annual Phase IV Clinical Trials-Design Research Programs to Meet Clinical, Regulatory, and Marketing Objectives.  Philadelphia, PA.  (2006, September).  Conference Presentation.

Staubach, L.B.,  “Drug Development Perspective-Pharma and Managed Care/Payer Groups Address Critical Issues Dealing with Pharmaceutical Utilization and Cost Control.”  The CBI 3rd Annual Forum on Formulary and Reimbursement Strategies for Effective Product Planning.  King of Prussia, PA. (2006, September). Conference presentation and panel discussion., 

Staubach, L.B.,  “Excellence in Pediatric Gastroenterology Education Award- An Overview.”  Association of Pediatric Gastroenterology and Nutrition Nurses (APGNN) Annual Planning Conference.  Savannah, GA.  (2006, September).  Presentation.

Staubach, L.B.,  “Evidence-Based Marketing-Integrate Scientific Evidence Into Your Everyday Marketing Programs.”  Evidence-Based Medicine For Pharmaceutical Marketing-Data-Driven Models For Global Branding and Credible Product Differentiation.  Philadelphia, PA.  (2006, January).  Conference presentation and panel discussion.

Staubach, L.B.,  “CME Guidelines and Their Impact on KOLs.”  2nd Annual Forum on Defining Appropriate and Effective Interactions With Thought Leaders and Key Opinion Leaders (KOLs)-Collaborate With Thought Leaders to Maximize Impact Throughout the Product Lifecycle.  Philadelphia, PA.  (2005, November).  Conference presentation.

Staubach, L.B.,  “Confidentiality With KOLs When Working With Multiple Sponsors.”  2nd Annual Forum on Defining Appropriate and Effective Interactions With Thought Leaders and Key Opinion Leaders (KOLs)-Collaborate With Thought Leaders to Maximize Impact Throughout the Product Lifecycle.  Philadelphia, PA.  (2005, November).  Conference presentation and panel discussion.

Staubach, L.B.,  “CME Guidelines and their Impact on KOLs.”  The Pharmaceutical Marketing Congress.  Philadelphia, PA. (2005, September).  Conference presentation.

Staubach, L.B.,  “Confidentiality with KOLs When Working With Multiple Sponsors.”  The Pharmaceutical Marketing Congress.  Philadelphia, PA. (2005, September).  Presentation and panel discussant.

Staubach, L.B.,  “Build a Physician Friendly CME Program- Understand What Physicians Want From CME Programs.”  The 5th Annual Continuing Medical Education (CME).  Princeton, NJ. (2005, June).  Conference presentation and panelist.

Staubach, L.B.,  “Minimize CME and CE Compliance Risks Through Adherence to the OIG Guidance Through its Enforcement of the Anti-kickback Statute.”  The 5th Annual Continuing Medical Education (CME).  Princeton, NJ. (2005, June).  Conference presentation.

Staubach, L.B.,  “Preparing For the Future of CME.”  The 5th Annual Continuing Medical Education (CME).  Princeton, NJ. (2005, June).  Conference presentation and panel discussion.

Staubach, L.B.,  “Create an Effective Balance Between Meeting Dissemination Objectives and Compliance Goals.”  2nd Annual Forum on Field-Based Dissemination of Scientific Information.  San Diego, CA. (2005, May). Conference presentation.

Staubach, L.B.,  “Ethics and Compliance of Drug Development and Commercialization - TAP Turns It Around.”  The 17th Annual Academy of Managed Care Pharmacy Meeting & Showcase.  Denver, CO. (2005, April).

Staubach, L.B.,  “Creating and Leveraging Sustained Competitive Advantage Through Your Strategic Contact Center.”  The IIR Optimizing the Value of Your Pharmaceutical Contact Center. Philadelphia, PA. (2004, July). Conference presentation.  

Staubach, L.B.,  “Chairperson’s Recap of Day One.”  The IIR Optimizing the Value of Your Pharmaceutical Contact Center. Philadelphia, PA. (2004, July).  Conference presentation.

Staubach, L.B. “Improving Contact Center Collaboration with Medical Communications, Marketing and Medical Affairs.”  The IIR Optimizing the Value of Your Pharmaceutical Contact Center. Philadelphia, PA. (2004, July).  Conference presentation and panel moderator.

Staubach, L.B.,  “Creating and Leveraging Sustainable Competitive Advantage From a Medical Liaison Function.”  2nd Annual Aligning Medical Affairs With Marketing.  Princeton, NJ.  (2004, April).  Conference presentation.

Staubach, L.B.,  “Detection and Management of High Utilizers.”  Senior Management Briefing 10-Primary Care Integration, Behavioral Healthcare Tomorrow-Building THE High-Performance Behavioral Healthcare Community.  Washington, DC.  (1997, September).  Conference presentation and panelist.

Staubach, L.B.,  “Recognizing the Role of the Worried Well in the Delivery of Primary Care.”  Symposium 10: Collaborative Clinical Services and Professions- The 3rd National Primary Care Behavioral Healthcare Summit.  Philadelphia, PA.  (1997, November).  Conference presentation and symposium chair.

Staubach, L.B. and Todd, W.,  “Demand Management Strategies for the Worried Well and the Chronically Ill Patient.”  Personalized Health Management:  Integrating Prevention, Wellness and Fitness Within Managed Care.  Philadelphia, PA. (1996, November).  Conference presentation.

Aforismo J, Kaul A, Tomondy P, Parry G, Staubach LB, Regalli G, and Dine.  “Flouroquinolone use for acute cystitis in an IPA-model managed care organization.”  The Academy of Managed Care Pharmacy Educational Conference. Anaheim, CA. (1994, October).  Conference presentation.

Staubach, L.B.,  “Adverse Experience Information Management- An OTC Perspective.”  Drug Information Association Meeting “Management of Adverse Experience Information.  New Orleans, LA. (1991, October).  Conference presentation.

Staubach, L.B.,  “The Psychology of Organizational Transition: transfers, Corporate Restructuring, Mergers, and Acquisitions.”  Executive MBA Class for Xavier University.  Cincinnati, OH.  (1991, October).  Interactive workshop.

Staubach, L.B.,  “The Psychology of Organizational Transition: transfers, Corporate Restructuring, Mergers, and Acquisitions.”  Executive MBA Class for Xavier University.  Cincinnati, OH.  (1990, October).  Interactive workshop.

Staubach, L.B.,  “Corporate Level Monitoring and Risk Management Intervention in the Physician-Related Areas of Credentialing and Peer Review.”  ASHRM National Conference.  Washington, DC.  (1987, October).  Conference presentation.

Share This Page:

Footer Navigation

University of Wyoming
 
1000 E. University Ave. Laramie, WY 82071 // UW Operators (307) 766-1121 // Contact Us